Skip to content

Insider · CIK 0001714023

Reine Allan

Reports to the SEC for 3 companies · CAMBRIDGE, MA

Transactions

21

Companies

3

Filings

16

CIK

0001714023

Forms 4 and 5

Insider transactions

21 trades
DateCompanyValue
2026-02-26PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award—
2025-08-01PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2025-08-01PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award—
2025-05-21PRMEPrime Medicine, Inc.P Purchase+$147K
2025-05-19PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award—
2025-05-08PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award—
2025-02-27PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award—
2024-12-05PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award—
2024-05-17PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award—
2024-01-17PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award—
2023-01-26FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award—
2022-01-26FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award—
2021-08-09FHTXFoghorn Therapeutics Inc.M Exercise/Conversion+$100K
2021-08-09FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)M Exercise/Conversion—
2021-01-28FHTXFoghorn Therapeutics Inc. · Stock Option (Right to Buy)A Award—
2019-02-26PVLAPALVELLA THERAPEUTICS, INC. · Stock Options (Right to Buy)A Award—
2018-02-20PVLAPALVELLA THERAPEUTICS, INC. · Stock Options (Right to buy)A Award—
2018-02-20PVLAPALVELLA THERAPEUTICS, INC. · Stock Options (Right to buy)A Award—
2017-08-17PVLAPALVELLA THERAPEUTICS, INC.P Purchase+$97.8K
2017-08-16PVLAPALVELLA THERAPEUTICS, INC.P Purchase+$216K
2017-08-09PVLAPALVELLA THERAPEUTICS, INC. · Common StockA Award—

Recent filings

16